Seriously, how common are these surnames? Just started researching the competition treatments crossmatched to surnames (just in case), and came across the following:
Infliximab (used in Pediatric GvHD currently but does not have durability of response, from the article I've read - https://pubmed.ncbi.nlm.nih.gov/17618323/)
https://pubmed.ncbi.nlm.nih.gov/26997425/ (Hinrichs)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765250/ (Halabi)
Are they like the Smith and Jones of England? Does anyone know?
Ryoncil: ODAC/FDA Meeting Discussion, page-2043
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.105(8.37%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.23 | $1.14 | $9.583M | 8.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |